Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116012
Status:
COMPLETED
Last Update Posted:
2006-11-29
First Post:
2005-06-26
Brief Title:
Anticoagulation With rNAPc2 to Eliminate MACETIMI 32
Sponsor:
ARCA Biopharma Inc
Organization:
ARCA Biopharma Inc
Organization Data
Organization:
ARCA Biopharma Inc
Class:
INDUSTRY
Study ID:
NUVO-0201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ARCA Biopharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The TIMI Study Group | OTHER |